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ABSTRACT
Objectives: To evaluate the efficacy of blood transfusion compared to no intervention in obstetric patients.
Material and methods: A systematic review was performed with Cochrane Database of Clinical Trials, PubMed, EMBASE 
and LILACS databases searched as of September, 2016. Two authors independently selected relevant clinical trials, assessed 
their methodological quality and extracted data, using the GRADE approach.
Results: Five studies within a total of 6,297 met the inclusion criteria, with women generally aged 20–40 years. Three included 
studies allocated women to receive blood transfusion or no intervention. Two other studies allocated women with either 
restricted or full blood supplies. The major issue regarding risk of bias was the extent of concealment of randomization 
and blinding. There was no statistically significant difference between blood transfusion versus no transfusion or restricted 
blood supply on mortality (relative risk 0.82 [95% confidential interval 0.32 to 2.09], p = 0.68; two studies; I2 = not applicable). 
Conclusions: Very low-quality evidence suggests no significant difference between blood transfusion and no intervention 
in obstetric patients, underlining the need for more robust clinical trials evaluating this area.
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INTRODUCTION
International rates of obstetric transfusions vary from 
0.1 to 1.9% and have increased in recent years [1]. Transfu-
sion of blood products is associated with extremely severe 
maternal morbidity and at least 26% of deaths secondary 
to postpartum haemorrhage are due to absence of blood 
transfusion [2]. The goal of transfusion is to increase pa-
tient survival while seeking the diagnosis and/or therapy 
to become effective. However, blood transfusion should 
not be administered unnecessarily, as it is a risk factor for 
hospital infection and recurrence of cancer and leads to 
complex changes in the immune system and are. In addition, 
there is no consensus on patient profiles warranting blood 
transfusion, and what haemoglobin concentration is most 
effective and safe to decrease the likelihood of morbidity 
and mortality. As pregnancy is an aggravating situation to 
the clinical picture of patients and may trigger additional 
complications to them, the fetus and the newborn [3], we 
focus this study on this clinical situation. The purpose of our 
systematic review is to evaluate the efficacy and safety of 
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blood transfusion compared to no intervention in obstetric 
labour patients.
MATERIAL AND METHODS
This systematic review of the literature on interven-
tional studies was conducted in accordance with the PRIS-
MA (Preferred Reposting Items for Systematic Reviews and 
Meta-analysis) statement [4].
Eligibility criteria
 Ū Study designs: randomized controlled trials (RCTs) 
and controlled clinical trials (CCTs) studies.
 Ū Participants: obstetric patients, regardless of indi-
cation for blood transfusion (e.g. anemia, shock, 
postpartum haemorrhage).
 Ū Interventions: women receiving blood transfusion.
 Ū Control group: women not receiving blood transfu-
sion (i.e. no intervention) or restricted blood prod-
uct. 
 Ū Outcomes:
•	 Mortality after delivery;
•	 Cardiovascular complications (myocardial in-
farction; needing cardiovascular devices; severe 
arrhythmia; or congestive heart failure);
•	 Physical fatigue postpartum; and
•	 Other related clinical outcomes reported by the 
included studies.
Studies were excluded if there were duplicate publica-
tions of a study that had already been included, or was 
an animal study, case report or review article.
Search strategy
The search was performed in the following electronic da-
tabases: Cochrane Database of Clinical Trials (CENTRAL, 2015, 
issue 09), PubMed (1966 to 2015), EMBASE (1980 to 2015), 
and LILACS (1982 to 2015). The databases were searched for 
available published and unpublished studies until September 
2nd, 2015. The search was conducted using multiple combina-
tions of the following key words: triggers; blood transfusion 
and; obstetric patients (Table 1). There was no restriction on 
language, year of publication or publication status.
In addition, a manual search of the bibliographic pages 
of the selected articles and the content pages of major 
journals was conducted. Study authors were contacted to 
identify additional studies.
Study selection and data extraction
The titles and abstracts were reviewed by two research-
ers to identify potentially relevant papers. The papers were 
obtained and independently read in full by the two review-
ers. Differences were resolved by discussion and a third 
party if necessary. Reasons for exclusion were identified. The 
data were also extracted independently by paired review-
ers based on the a priori inclusion and exclusion criteria 
defined above.
Risk of bias in individual studies
Paired reviewers independently assessed the risk of bias 
of included RCTs using a modified version of the Cochrane 
Collaboration’s instrument (http:/distillercer.com/resourc-
es/) [5, 6]. The instrument includes nine domains: adequacy 
of sequence generation, allocation sequence concealment, 
blinding of participants and caregivers, blinding of data 
collectors, blinding for outcome assessment, blinding of 
data analysts, incomplete outcome data, selective outcome 
reporting, and the presence of other potential sources of 
bias not accounted for in the previously cited domains [6].
When information regarding risk of bias or other aspects 
of methods or results was unavailable, we attempted to 
contact study authors for additional information.
Assessment of heterogeneity
We quantified inconsistency among pooled estimates 
by using the I2 statistic. This illustrates the percentage of 
variability in effect estimates that results from heteroge-
neity rather than from sampling error [7, 8]. We intended 
to examine forest plots for CI overlap and to calculate the 
Chi2 test for homogeneity with a 10% level of significance.
Table 1. Search strategy for all electronic databases
(((Blood Transfusions OR Blood Transfusion OR Trigger Blood 
Transfusions OR Trigger Blood Transfusion OR Replacement of 
blood loss OR transfusion OR transfusion therapy OR red blood cell 
transfusion OR blood products OR blood transfusion practices OR 
Packed- Blood-Cell Transfusion OR Packed Blood Cell Transfusion OR 
hemotransfusions OR transfusion of red blood cells OR exchange 
transfusion) AND (Pregnancy OR Pregnancies OR Gestation OR 
pregnant women OR parturient OR parturients OR caesarean section 
OR cesarean delivery OR normal birth OR normal childbirth OR normal 
delivery OR natural childbirth OR postpartum blood transfusion 
OR postpartum haemorrhage OR anaemic women OR anaemia 
in pregnancy OR anaemic parturient OR anaemicparturients OR 
obstetric patients OR obstetric patient OR women with acute 
anaemia OR acute postpartum anemia OR maternal hemorrhage)) 
AND (randomized controlled trial [Publication Type] OR controlled 
clinical trial [Publication Type] OR randomized controlled trials [MeSH 
Terms] OR random allocation [MeSH Terms] OR double blind method 
[MeSH Terms] OR single blind method [MeSH Terms] OR clinical trial 
[Publication Type] OR clinical trials [MeSH Terms] OR (clinical* [Text 
Word] AND trial* [Text Word]) OR single* [Text Word] OR double* 
[Text Word] OR treble* [Text Word] OR triple* [Text Word] OR placebos 
[MeSH Terms] OR placebo* [Text Word] OR random* [Text Word] OR 
research design [MeSH Terms] OR comparative study [MeSH Terms] OR 
evaluation studies [MeSH Terms] OR follow-up studies [MeSH Terms] 
OR prospective studies [MeSH Terms] OR control* [Text Word] OR 
prospectiv* [Text Word] OR volunteer* [Text Word])) AND (human OR 
humans)
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Certainty of evidence
We summarized the evidence and assessed its certainty 
for bodies of evidence from RCTs. We were not able to per-
form a summary of findings table for controlled clinical 
trials (CCTs) as there was no further data provided by them. 
We used the Grading of Recommendations Assessment, 
Development and Evaluation (GRADE) methodology to rate 
certainty of the evidence for each outcome as high, moder-
ate, low, or very low [9]. Detailed GRADE guidance was used 
to assess overall risk of bias [10], imprecision [11], inconsist-
ency [12], indirectness [13] and publication bias [14], and to 
summarize results in an evidence profile.
We planned to assess publication bias through visual 
inspection of funnel plots for each outcome in which we 
identified 10 or more eligible studies; however, we were 
not able to do so, due to an insufficient number of studies 
to allow for this assessment. 
Data synthesis and statistical analysis
We analyzed all outcomes as dichotomous variables. We 
calculated pooled Mantel-Haenszel risk ratios (RRs) and 
associated 95% CIs using random-effects models. We con-
sidered studies that allocated women to full blood supply 
as the intervention group, and those studies that allocated 
women to restricted blood supply as the control group.
We assessed variability in results across studies by us-
ing the I2 statistic and the p-value for the chi square test 
of heterogeneity provided by Review Manager. We used 
Review Manager (RevMan) (version 5.3; Nordic Cochrane 
Centre, Cochrane) for all analyses [15].
RESULTS
Search results
Figure 1 presents the process of identifying eligible stud-
ies, including citations identified through search in electronic 
databases, and studies identified through contact with ex-
perts in the field. Based on title and abstract screening, we 
assessed 31 full-texts of which we included five publications 
describing three RCTs [16–18] involving 1,090 participants 
and, two CCTs [19, 20] with a total of 5,207 participants.
Characteristics of included studies
Table 2 describes study characteristics related to design 
of study, setting, number of participants, mean age, gender, 
inclusion and exclusion criteria, and follow-up. Two studies 
[19, 20] were conducted largely in Asia, two others in Africa 
[16, 18], and one in Europe [17]. Randomized trials sample 
size ranged from 50 [18] to 521 [17], and controlled clinical 
trials studies from 1,769 [20] to 3,438 [19], and typically 
included females between the ages of 20 and 40 years. Stud-
ies followed participants for six weeks in one study [17]; the 
other studies did not report follow-up duration.
Three included studies [17, 19, 20] allocated women to 
receive blood transfusion or no intervention and two others 
[16, 18] provided women with either restricted or full blood 
supplies (Table 2). 
Risk of bias in included studies
Figure 2 and Table 3 describe the risk of bias assessment 
for the RCTs and CCTs. The major issue regarding risk of bias 
was the extent of allocation concealment and blinding of 
participants, caregivers, data collectors, statistician, and 
outcome assessors in all the included studies [16–20]. Only 
one study [18] had additional problems of missing outcome 
data, and three other studies [16, 19, 20] had issues related 
to generation of allocation. 
Effectiveness of interventions
Mortality after delivery
Figure 3 shows the meta-analysis comparing blood 
transfusion versus no transfusion or restricted supply blood 
# of records 
screened 8.140
# of records 
after duplicates 
removed 8.140
PubMed 5.884
EMBASE 1.178
CENTRAL 795
LILACS 283
# of records 
excluded 8.109
# of full-text 
articles assessed 
for eligibility 31
# of studies included 
in qualitative synthesis 5
# of full-text articles 
excluded, 
with reasons 26
Non-RCT 
or retrospective 
studies 26
# of studies included 
in quantitative 
synthesis 5 
(meta-analysis 
or representation
or meta-analysis) 3
# of records identied 
through database 
searching 8.487
PubMed 6.227
EMBASE 1.182
CENTRAL 795
LILACS 283
# of additional records
identied through 
other sources 0
Figure 1. Flowchart of the review
449
Celso Módolo et al., Blood transfusion in obstetric patients
www. journals.viamedica.pl/ginekologia_polska
Ta
bl
e 
2.
 S
tu
dy
 ch
ar
ac
te
ris
tic
s r
el
at
ed
 to
 d
es
ig
n 
of
 st
ud
y,
 co
un
tr
y,
 n
um
be
r o
f p
ar
tic
ip
an
ts
, m
ea
n 
ag
e,
 in
cl
us
io
n 
an
d 
ex
cl
us
io
n 
cr
ite
ria
, a
nd
 fo
llo
w
-u
p
Au
th
or
, y
ea
r
D
es
ig
n 
 
of
 st
ud
y
Lo
ca
tio
n
N
o.
* 
pa
rt
ic
ip
an
ts
M
ea
n 
ag
e
In
cl
us
io
n 
cr
ite
ria
Ex
cl
us
io
n 
cr
ite
ria
Fo
llo
w
-u
p
Ra
nd
om
iz
ed
 co
nt
ro
lle
d 
tr
ia
ls
 (R
CT
)
O
se
i, 2
01
3 
[1
6]
Pa
ra
lle
l
RC
T
Af
ric
a
T:
 2
49
 
N
T:
 2
70
30 (n
ot
 sp
ec
ifi
ed
 
by
 g
ro
up
)
Al
l p
at
ie
nt
s w
ho
 re
ce
iv
ed
 b
lo
od
 d
ur
in
g 
th
e 
st
ud
y 
pe
rio
ds
 w
er
e 
el
ig
ib
le
 a
nd
 w
er
e 
in
cl
ud
ed
 u
nl
es
s 
re
fu
sin
g 
co
ns
en
t
Pa
tie
nt
s w
ho
 re
fu
se
d 
co
ns
en
t
N
R
Pr
ic
k,
 2
01
0 
[1
7]
Pa
ra
lle
l
RC
T
Eu
ro
pe
T:
 2
59
N
T:
 2
62
 T:
 3
0.
7
N
T:
 3
0.
9
W
om
en
, o
ld
er
 th
an
 1
8 
ye
ar
s o
f a
ge
, w
ho
 d
el
iv
er
 
in
 h
os
pi
ta
l o
r a
re
 tr
an
sf
er
re
d 
af
te
r h
om
e 
de
liv
er
y 
be
ca
us
e 
of
 p
rim
ar
y 
po
st
pa
rt
um
 h
ae
m
or
rh
ag
e 
(P
PH
), 
ar
e 
el
ig
ib
le
. P
at
ie
nt
s w
ill
 b
e 
in
cl
ud
ed
 w
ith
 a
n 
H
b 
be
tw
ee
n 
3.
0 
an
d 
5.
0 
m
m
ol
/L
 (4
.8
 a
nd
 8
.1
 g
/d
L)
, 
de
te
rm
in
ed
 1
2 
to
 2
4 
ho
ur
s a
fte
r v
ag
in
al
 d
el
iv
er
y 
or
 
ca
es
ar
ea
n 
se
ct
io
n,
 a
nd
 a
 d
ec
re
as
e 
in
 H
b 
of
 a
t l
ea
st
 
1.
2 
m
m
ol
/L
 (1
.9
 g
/d
L)
 a
nd
/o
r a
 to
ta
l p
er
ip
ar
tu
m
 b
lo
od
 
lo
ss
 o
f a
t l
ea
st
 1
00
0 
m
L.
 T
he
 in
iti
al
 H
b 
va
lu
e 
w
ill
 b
e 
de
te
rm
in
ed
 w
he
n 
th
e 
pa
tie
nt
 is
 a
dm
itt
ed
 d
ur
in
g 
th
e 
fir
st
 st
ag
e 
of
 la
bo
ur
 a
t t
he
 la
bo
ur
 w
ar
d.
 In
 o
th
er
 
in
st
an
ce
s, 
w
he
n 
an
 in
iti
al
 H
b 
is 
ab
se
nt
, in
cl
us
io
n 
is 
pu
re
ly
 b
as
ed
 o
n 
th
e 
to
ta
l a
m
ou
nt
 o
f b
lo
od
 lo
ss
. F
in
al
ly
, 
go
od
 w
or
ki
ng
 k
no
w
le
dg
e 
of
 th
e 
D
ut
ch
 la
ng
ua
ge
 is
 
re
qu
ire
d
Ex
cl
us
io
n 
cr
ite
ria
 in
cl
ud
e 
se
ve
re
 (a
na
em
ic
) p
hy
sic
al
 
co
m
pl
ai
nt
s, 
pr
ev
io
us
 R
BC
 tr
an
sf
us
io
n 
di
re
ct
ly
 
af
te
r d
el
iv
er
y, 
se
ve
re
 p
re
-e
cl
am
ps
ia
, s
ev
er
el
y 
ac
tiv
e 
in
fe
ct
io
us
 d
ise
as
e,
 c
on
ge
ni
ta
l h
ae
m
ol
yt
ic
 
di
se
as
e,
 se
ve
re
 c
om
pr
om
ise
d 
im
m
un
ol
og
ic
al
 
st
at
us
, m
al
ig
na
nc
y, 
se
ve
re
 c
o-
m
or
bi
di
ty
 (A
SA
 II
/II
I),
 
pe
rip
ar
tu
m
 d
ea
th
 o
r c
rit
ic
al
 c
on
di
tio
n 
of
 th
e 
ne
w
bo
rn
. 
Se
ve
re
 (a
na
em
ic
) p
hy
sic
al
 c
om
pl
ai
nt
s w
er
e 
de
fin
ed
 
as
 fa
tig
ue
, h
ea
da
ch
e,
 d
iz
zi
ne
ss
, c
on
fu
sio
n,
 d
ys
pn
oe
a,
 
sy
nc
op
e,
 o
rt
ho
st
at
ic
 c
om
pl
ai
nt
s, 
ta
ch
yc
ar
di
a 
 
(>
 1
00
 b
pm
), 
an
gi
na
 p
ec
to
ris
 a
nd
/o
r t
ra
ns
ie
nt
 is
ch
em
ic
 
at
ta
ck
s (
TI
A)
Si
x 
w
ee
ks
Ph
ilp
ot
t, 
19
66
 [1
8]
Pa
ra
lle
l
RC
T
Af
ric
a
T:
 2
5 
N
T:
 2
5
25
.7
 
(n
ot
 sp
ec
ifi
ed
 
by
 g
ro
up
)
Al
l p
at
ie
nt
s w
ho
se
 h
ae
m
og
lo
bi
n 
le
ve
l w
as
 b
el
ow
 
4.
4 
g/
10
0 
m
L 
(3
0%
), 
w
ho
 d
id
 n
ot
 m
an
ife
st
 e
vi
de
nc
e 
of
 sh
oc
k,
 a
nd
 w
ho
 h
ad
 b
ee
n 
ad
m
itt
ed
 to
 th
e 
gy
na
ec
ol
og
ic
al
 a
nd
 o
bs
te
tr
ic
 u
ni
ts
 a
t K
in
g 
Ed
w
ar
d 
VI
II 
Ho
sp
ita
l, D
ur
ba
n
N
R
N
R
Co
nt
ro
lle
d 
cl
in
ic
al
 tr
ia
ls
 (C
CT
)
Ism
ai
l, 
20
14
 [1
9]
CC
T
As
ia
n
T:
 3
97
N
T:
 3
04
1
T:
 2
8.
7
N
T:
 2
7.
6
Al
l p
at
ie
nt
s u
nd
er
go
in
g 
em
er
ge
nc
y 
an
d 
el
ec
tiv
e 
CS
 
du
rin
g 
th
e 
st
ud
y 
pe
rio
d
N
R
N
R
Go
un
da
n,
 
20
11
 [2
0]
CC
T
As
ia
n
T:
 2
16
 
N
T:
 1
55
3
T:
 2
6.
78
 
N
T:
 2
7.
01
Al
l w
om
en
 w
ho
 u
nd
er
w
en
t c
es
ar
ea
n 
de
liv
er
y 
du
rin
g 
th
e 
pe
rio
d 
be
tw
ee
n 
M
ay
 2
00
7 
an
d 
N
ov
em
be
r 2
00
8
N
R
N
R
CC
T 
—
 c
on
tro
lle
d 
cl
in
ic
al
 tr
ia
l; 
N
R 
—
 n
ot
 re
po
rt
ed
; N
T 
—
 n
ot
 tr
an
sf
us
ed
; R
CT
 —
 ra
nd
om
iz
ed
 c
on
tro
lle
d 
tr
ia
l; T
 —
 tr
an
sf
us
ed
450
Ginekologia Polska 2017, vol. 88, no. 8
www. journals.viamedica.pl/ginekologia_polska
on mortality. There was no statistically significant difference 
between both studied groups (RR 0.82 [95% CI 0.32 to 2.09], 
p = 0.68; two studies [16, 18]; I2 = not applicable).
Cardiovascular events and physical fatigue
Only Philpott 1966 et al.’s study [18] reported on car-
diovascular complications; the study reported no events 
in each of the studied groups. Prick et al.’s 2010 [17] study 
reported a mean physical fatigue score at day three and one 
week postpartum as reduced by 0.8 and 1.06, respectively, 
in the transfusion arm compared to women receiving no 
intervention. 
DISCUSSION
Main findings
Based on pooled data from two randomized trials with 
569 participants, we did not find evidence for a possible 
benefit in clinical outcomes with blood transfusion in com-
parison to no intervention for obstetric patients (Figure 3). 
The evidence was of very low certainty: the 95% confidence 
interval of the relative risk crossed 1.0 and the high risk of 
bias associated with allocation concealment and blinding 
yielded results that were inconsistent (Table 4). 
Relation to prior work
A systematic review [21] about the effectiveness of in-
terventions for management (e.g. pharmacologic or medical 
management, but not limited to transfusion) of postpartum 
haemorrhage, using Medline, EMBASE, Cumulative Index to T
ab
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Nursing and Allied Health Literature (CINAHL) databases 
for only articles published in English, identified a total of 
68 studies. The authors concluded that the literature com-
prised studies of high risk of bias with a small number of 
participants and, therefore no conclusions could be drawn 
from the actual evidence. 
Strengths and limitations
Strengths of our review include a comprehensive search; 
assessment of eligibility, risk of bias, and data abstraction 
independently and in duplicate; assessment of risk of bias; 
and use of the GRADE approach in rating the certainty of 
evidence for each outcome.
The primary limitation of our review is the very low cer-
tainty consequent on study limitations. We identified only 
a small number of studies with heterogeneous outcomes 
measurements, making only possible a meta-analysis with 
only two RCTs for mortality and resulting in wide confidence 
intervals. Moreover, high risk of bias in terms of allocation 
concealment and blinding limited the certainty of the evi-
dence, making it challenging to draw credible inferences.
CONCLUSIONS
Given the low quality of the available evidence, our 
findings provide very limited support for the hypothesis 
that blood transfusion may be more effective than no in-
tervention for obstetric patients. This review underlines the 
urgent need to conduct well-designed trials in the use of 
blood transfusion.
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